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Abstract
Recently, the diversity of the Mycobacterium tuberculosis complex (MTBC) population structure has been described in detail.
Based on geographical separation and specific host pathogen co-evolution shaping MTBC virulence traits, at least 20 major
lineages/genotypes have evolved finally leading to a clear influence of strain genetic background on transmissibility, clinical
presentation/outcome, and resistance development. Therefore, high resolution genotyping for characterization of strains in
larger studies is mandatory for understanding mechanisms of host-pathogen-interaction and to improve tuberculosis (TB)
control. Single nucleotide polymorphisms (SNPs) represent the most reliable markers for lineage classification of clinical
isolates due to the low levels of homoplasy, however their use is hampered either by low discriminatory power or by the
need to analyze a large number of genes to achieve higher resolution. Therefore, we carried out de novo sequencing of 26
genes (approx. 20000 bp per strain) in a reference collection of MTBC strains including all major genotypes to define a
highly discriminatory gene set. Overall, 161 polymorphisms were detected of which 59 are genotype-specific, while 13
define deeper branches such as the Euro-American lineage. Unbiased investigation of the most variable set of 11 genes in a
population based strain collection (one year, city of Hamburg, Germany) confirmed the validity of SNP analysis as all strains
were classified with high accuracy. Taken together, we defined a diagnostic algorithm which allows the identification of 17
MTBC phylogenetic lineages with high confidence for the first time by sequencing analysis of just five genes. In conclusion,
the diagnostic algorithm developed in our study is likely to open the door for a low cost high resolution sequence/SNP
based differentiation of the MTBC with a very high specificity. High throughput assays can be established which will be
needed for large association studies that are mandatory for detailed investigation of host-pathogen-interaction during TB
infection.
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Introduction
With one-third of the world’s population infected and approx-
imately 2 million individuals dying of tuberculosis (TB) annually,
bacteria of the Mycobacterium tuberculosis complex (MTBC) are
among the most harmful pathogens [1]. The interaction of M.
tuberculosis with HIV and the emergence of multidrug-resistant
strains are further accelerating the TB epidemic [2]. Even more
worrisome is that, in spite of nearly 100 years of intensive research,
no vaccines are available to effectively protect adults from the
development of pulmonary TB [3]. Thus, new approaches for
understanding pathogenesis and disease dynamics are urgently
needed.
The MTBC comprises seven closely related species with distinct
host tropism: M. tuberculosis, M. africanum and M. canettii strains are
obligate human pathogens, while M. bovis (bovine), M. caprae
(goats), M. microti (rodents) and M. pinnipedii (seals) are considered
as animal adapted organism [4–6]. Furthermore, recent studies
demonstrate that these species can be subdivided in manifold
phylogenetic lineages that show significant levels of functional
genome variation and pathobiological characteristics [5–8].
First insights into the global population structure and the
phylogenetic lineage composition have been gained by IS6110
restriction fragment length polymorphism DNA fingerprinting
(IS6110 RFLP) and spacer oligonucleotide typing (spoligotyping)
[9–11]. Following, large sequence and single nucleotide polymor-
phisms (LSP and SNP) have been successfully used to classify
clinical isolates into main lineages with high specificity [6–8,12].
However, due to the high similarity of MTBC strains on the
genome level resolution was low when a practicable number of
markers are analyzed [13]. More recently, multi locus variable
number of tandem repeats (VNTR) analysis targeting 24
mycobacterial interspersed repetitive units (MIRU) has been
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simultaneously the investigation of strain transmission in epide-
miological studies as well as the phylogenetic lineage classification
of clinical isolates [14,15].
However, when we compared the performance of spoligotyping,
MIRU-VNTR-typing and sequence based (SNP) data for phylo-
genetic classification of a reference collection comprising major
MTBC lineages, it turned out, that phylogenies inferred from
spoligotyping or 15-loci-MIRU-VNTR were incongruent (mainly
due to high levels of homoplasy), while phylogenetic trees derived
from multilocus sequence data were highly congruent and
statistically robust [16]. 24-loci-MIRU-VNTR led to higher
resolution; however, it still was unable to detect all strain lineages
with high statistical support [16]. These findings confirm that
SNPs are more suited than MIRU-VNTR for defining deep
phylogenetic groupings with very high confidence.
However, as outlined above, it is difficult to define a high
discriminatory sequence based assay based on a limited number of
targets due to the comparatively low sequence variability in
clinical MTBC isolates [8,17,18]. Furthermore, the phylogenetic
performance of SNP typing has mainly been investigated in
reference strain collections [18]. An evaluation of specificity and
sensitivity of SNP based lineage identification in population based
epidemiological studies has not been carried out so far.
In this study, we accomplished de novo sequencing of 26 genes in
68 clinical isolates that represent all major phylogenetic lineages
present in the MIRU-VNTRplus data base (www.MIRU-
VNTRplus.org) [14,19] in order to establish a sequence based
assay with high discriminatory power. Sequence variations in the
most variable 11 genes were evaluated in a population based study
including strains obtained during one year of a longitudinal
epidemiological survey carried out in Hamburg, Germany.
Finally, based on these data, we designed a diagnostic algorithm
including sequence analysis of just five genes that allow the
classification of clinical isolates in 17 phylogenetic lineages in an
easy, cost effective and highly specific way.
Materials and Methods
Bacterial Strains
Sequence analysis of 26 genes (Table 1) was carried out in 65
clinical isolates (Table 2) of the MIRU-VNTRplus reference
collection [14,19] as well as the ATCC reference strains H37Rv
(ATCC 27294), M. africanum (ATCC 25420), and M. bovis (ATCC
19210). 21 different species/genotypes were represented by three
clinical isolates (exception M. pinipedii: 2 strains). The targeted
analysis of 11 genes was carried out in 104 strains collected during
one year (2007) of an ongoing population based molecular
epidemiological survey in Hamburg, Germany (Table S2).
All strains were analyzed by 24-loci-MIRU-VNTR and
spoligotyping. Strains of the reference collection were further
investigated by deletion analysis (region of difference; RD) to
confirm phylogenetic classification (details at www.MIRU-
VNTRplus.org).
DNA Techniques
Extraction of DNA from mycobacteria was performed accord-
ing to a standardized protocol [11]. All isolates were analyzed by
spoligotyping [9] and 24 loci MIRU-VNTR as described
previously [15]. The presence or absence of 16 RDs was analyzed
by PCR using standard protocols available at the MIRU-
VNTRplus webpage (www.MIRU-VNTRplus.org) [19].
For DNA sequence analysis 26 genes (Table 1) were amplified
by polymerase chain reaction. Primer sequences are summarized
in Table S1. Direct sequencing of PCR fragments was carried out
using a commercially available sequencing kit (BigDye terminator
v1.1, Applied Biosystems, Foster City, USA) and the ABI 3130XL
sequencer according to the manufactures instructions (Applied
Biosystems).
Computer Analysis
Molecular typing data were analyzed with the BioNumerics
software (version 6.5; Applied Maths, Sint-Martens-Latem,
Belgium) as instructed by the manufacturer. Similarities of
spoligotyping and MIRU-VNTR patterns were calculated by
using the categorical coefficient. Classification of the Hamburg
strain collection in MTBC genotypes was carried out by using
the MIRU-VNTRplus database [14,19]. Analysis of sequence
data and SNP detection was performed by using SeqScape v2.6
software (Applied Biosystems). Genome sequences of M.
tuberculosis H37Rv (http://tuberculist.epfl.ch/) were used as a
reference sequence. Calculation of a maximum parsimony
phylogenetic tree based on SNP data of the Hamburg strain
collection was performed with BioNumerics. A maximum
likelihood phylogenetic tree was constructed based on an
alignment of SNPs discovered in 26 genes from the reference
collection isolates by applying Treefinder software (available at
http://www.treefinder.de/) and using the HKY model of DNA
Table 1. 26 Genes investigated.
Rv - number Gene
whole gene
sequence
Gene
(bp) PCR (bp)
Rv0129c fbpC yes 1023 1304
Rv0288 esxH yes 291 788
Rv0388c ppe9 yes 543 713
Rv0407 fgd1 yes 1011 1606
Rv0410c pknG yes 2253 2620
Rv0557 mtfB yes 1137 1340
Rv1009 rpfB yes 1089 1360
Rv1617 pykA no 1419 315
Rv1811 mgtC yes 705 880
Rv1884c rpfC yes 531 689
Rv1908c katG no 2223 1061
Rv1980c mpt64 yes 687 858
Rv2032 Acg yes 996 1359
Rv2389c rpfD yes 465 836
Rv2428 ahpC no 588 237
Rv2430c ppe41 yes 585 796
Rv2431c pe25 yes 300 649
Rv2450c rpfE yes 519 938
Rv2609c – yes 1056 1314
Rv2610c pimA yes 1137 1302
Rv2611c – yes 951 1175
Rv2612c pgsA1 yes 654 815
Rv2613c – yes 588 830
Rv2628 – yes 363 521
Rv2629 – yes 1125 1575
Rv3547 – yes 456 846
PCR: polymerase chain reaction.
doi:10.1371/journal.pone.0039855.t001
Genotyping of M. tuberculosis
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replicates.
More details about procedures for analysis of typing data are
described elsewhere [19–21].
Results
In this study we investigated the performance of sequence based
analysis for highly discriminatory phylogenetic classification of
clinical MTBC isolates using de novo sequencing of 26 genes or part
of the genes in a reference collection of 68 pre-selected MTBC
strains which represent all major phylogenetic lineages (three
strains for most of the lineages, Table 2). This collection included
54 strains of human-adapted (M. tuberculosis, M. africanum and
M. canettii) as well as 11 strains of animal adapted lineages (M. bovis,
M. microti, M. pinnipedii, M. caprae) and the ATCC strains H37Rv,
M. bovis and M. africanum. All strains were previously classified into
phylogenetic lineages based on spoligotyping, MIRU-VNTR and
deletion typing [19].
The analyzed genes comprised cell wall associated genes,
antigens, genes involved in metabolism, resuscitation factors and
other genes of special interest e.g. those that have been described
to have an overall higher mutation rate [7].
In total, we determined DNA sequences (exception: strain
8885/03 no sequence data for Rv2431c) of 20078 base pairs (bp)
for each strain which correspond to ,0.46% of the MTBC
genome. All sequences determined were compared to the H37Rv
reference genome to identify possible variations e.g. SNPs,
deletions or insertions. In total we found 161 sequence variations
resulting in an average mutation density of 1.18610
24/bp. As
described before, sequence variation was variable among the genes
investigated (Table S3). For example, antigens (Rv0288, Rv1980c)
are more conserved than cell wall associated genes (Rv0577).
Table 2. Strains of the reference collection.
Sample Name Species Genotype
1449/02 M. africanum West African 1a
1473/02 M. africanum West African 1a
5434/02 M. africanum West African 1a
10473/01 M. africanum West African 1b
10494/01 M. africanum West African 1b
1443/02 M. africanum West African 1b
10514/01 M. africanum West African 2
10517/01 M. africanum West African 2
5468/02 M. africanum West African 2
9550/00 M. africanum West African 2 ATCC
4258/00 M. bovis Bovis
751/01 M. bovis Bovis
7540/01 M. bovis Bovis
9564/00 M. bovis Bovis ATCC
3040/99 M. canettii Canettii
3041/99 M. canettii Canettii
3151/08 M. canetti Canettii
1694/00 M. caprae Caprae
8986/99 M. caprae Caprae
9577/99 M. caprae Caprae
416/01 M. microti Llama
8753/00 M. microti Llama
1479/99 M. microti Vole
7011/02 M. pinipedii Seal
7739/01 M. pinipedii Seal
12594/02 M. tuberculosis Beijing
1500/03 M. tuberculosis Beijing
1934/03 M. tuberculosis Beijing
1417/02 M. tuberculosis Cameroon
5390/02 M. tuberculosis Cameroon
5400/02 M. tuberculosis Cameroon
2637/02 M. tuberculosis Delhi/CAS
7936/01 M. tuberculosis Delhi/CAS
9915/01 M. tuberculosis Delhi/CAS
1797/03 M. tuberculosis EAI
4850/03 M. tuberculosis EAI
947/01 M. tuberculosis EAI
10469/01 M. tuberculosis Ghana
10493/01 M. tuberculosis Ghana
2570/02 M. tuberculosis Ghana
9679/00 M. tuberculosis H37Rv ATCC
2336/02 M. tuberculosis Haarlem
4130/02 M. tuberculosis Haarlem
9532/03 M. tuberculosis Haarlem
7968/03 M. tuberculosis LAM
8885/03 M. tuberculosis LAM
946/03 M. tuberculosis LAM
10459/03 M. tuberculosis New-1
12591/02 M. tuberculosis New-1
8870/03 M. tuberculosis New-1
Table 2. Cont.
Sample Name Species Genotype
2151/03 M. tuberculosis S-type
2318/06 M. tuberculosis S-type
6411/05 M. tuberculosis S-type
11313/03 M. tuberculosis TUR
10264/03 M. tuberculosis TUR
10529/03 M. tuberculosis TUR
2169/99 M. tuberculosis Uganda I
2201/99 M. tuberculosis Uganda I
2333/99 M. tuberculosis Uganda I
2176/99 M. tuberculosis Uganda II
2191/99 M. tuberculosis Uganda II
2253/99 M. tuberculosis Uganda II
1657/03 M. tuberculosis Ural
2679/03 M. tuberculosis Ural
8431/03 M. tuberculosis Ural
4412/04 M. tuberculosis X-type
8431/05 M. tuberculosis X-type
9953/04 M. tuberculosis X-type
CAS: Central Asien; EAI: East African Indian; LAM: Latin American Mediterranean;
TUR: Turkish.
doi:10.1371/journal.pone.0039855.t002
Genotyping of M. tuberculosis
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Turkish.
doi:10.1371/journal.pone.0039855.g001
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Central Asien; LAM: Latin American Mediterranean; TUR: Turkish.
doi:10.1371/journal.pone.0039855.g002
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(n=1, Table S5). In accordance with previous findings [7,16], the
majority of the 155 SNPs detected were non-synonymous
mutations (n=89, 57.42%, Table S3), while only 66 of them
were synonymous (42.58%).
Besides, 66 of all 155 SNPs detected were only found in the
three M. canettii strains investigated. Thereof a significantly higher
SNP density of 1.10610
23/bp could be calculated for M. canettii
(or M. prototuberculosis) strains confirming that these strains are
considered to have a longer evolutionary history. Accordingly, the
ratio of non-synonymous to synonymous polymorphisms was
much lower in comparison to other MTBC strains (25 (37.88%) vs.
41 (62.12%)).
As we correlate the occurrence of SNPs with the phylogenetic
strain classification, it appeared that out of the 161 polymorphisms
detected 59 SNPs are genotype-specific meaning that they were
only found in MTBC strains of one specific phylogenetic sub-
lineage e.g. strains of the Haarlem genotype or the Beijing
genotype (Figure 1, M. africanum West African 1a and 1b are
considered as one genotype in this context). An additional number
of 12 SNPs were found to be specific for deeper branches in the
phylogeny defining larger groups such as the Euro-American
lineage or so called clade 2 strains (Figure 1 and 2). One of the
detected deletions (Rv0388c_438delT) was specific for all M. bovis
and M. caprae strains investigated (Figure 1). In addition, all
phylogenetic informative SNPs correlate with the occurrence of
particular deletions e.g. the pks1/15 deletion that is specific for the
Euro-American lineage (Figure 2).
Overall, when using the genotype-specific SNPs, we were able
to discriminate nearly all lineages except the very closely related
M. tuberculosis genotypes New-1, Uganda and X-type as well as
M. microti and M. pinnipedii strains. Again, due to the much higher
number of polymorphisms, M. canettii strains showed the most
genotype specific variability (22/59) followed by M. africanum West
African 1 (9/59) and West African 2 isolates (5/59) (Figure 1). To
further investigate the phylogenetic informative content of the
generated data and the population structure of the strains
investigated, we calculated a maximum likelihood tree on the
basis of the polymorphisms detected (Figure 2). This sequence
based tree groups the analyzed MTBC isolates into the most
common phylogenetic lineages defined by MIRU-VNTR typing
and spoligotyping. The MTBC strains fall into three clearly
distinct major groups: clade 1 comprising the classical M.
tuberculosis strains, clade 2 comprising M. africanum and the animal
isolates, and clade 3 comprising the M. tuberculosis EAI strains that
are clearly separated from all other M. tuberculosis strains
investigated.
In comparison to previous studies, our analyses confirm that
sequence data are entirely suitable for the phylogenetic classifica-
tion of MTBC strains when well characterized strain collections
are analyzed [16]. However to further evaluate this notion in a
more unbiased manner we analyzed the most variable 11 of 26
genes in a population based collection of 104 MTBC strains
obtained in the year 2007 from tuberculosis patients living in
Hamburg, Germany by de novo sequencing. As a first step, all
strains were classified into phylogenetic lineages based on
spoligotyping (Table S2). This revealed a highly diverse population
structure comprising strains of several phylogenetic lineages
ranging from M. africanum West African 1, M. bovis,t oM.
tuberculosis EAI, Beijing, Delhi/CAS, Haarlem, Cameroon, Ghana,
LAM, S-type, TUR and Uganda strains. However, a larger group
of strains could not be allocated to a particular lineage and was
confirmed to belong to the Euro-American lineage based on
deletion typing of pks1/15 (data not shown).
The sequence data revealed the presence of 61 SNPs of which
41 were non-synonymous and 20 synonymous polymorphisms
(Table S4). In addition, 10 of the strains investigated had a 70 bp
deletion and three a 102 bp deletion (specific for the TUR
genotype) in Rv2450c (Table S6). Overall, 29 out of 61 SNPs
determined were SNPs previously found to be either genotype or
lineage specific in the reference collection. Again, the occurrence
of these SNPs was in nearly complete concordance with
phylogenetic strain classification based on MIRU-VNTR and
spoligotyping data. Only one strain was classified as ‘‘not defined’’
based on spoligotyping data (as no specific spoligotyping signature
was present) but had a SNP specific for the TUR lineage (Table
S2; 8918/07, Rv1009_1075g.A). Cluster analysis based on 24-
loci MIRU-VNTR typing data grouped this strain together with
the other three TUR strains investigated, thus, confirming the
SNP typing result (data not shown).
Interestingly, the sequence data also allowed the further sub-
classification of three strains of the EAI genotype into the EAI
‘‘Manila’’ sub-type [22] based on two SNPs (Rv0410c_2117t.C,
Rv1009_724g.A). In addition, the generated de novo sequence
data revealed a new SNP in Rv2628 (4t.C) that is specific for 18
strains of the Hamburg collection which were previously classified
into the Euro-American lineage, thus, most likely defining a new
genotype (Hamburg lineage). When spoligotyping data were
considered, these strains showed no clear criteria for close
relationship, while MIRU-VNTR typing grouped them together
(data not shown) confirming a clonal relationship. Finally, all
strains with the 70 bp deletion in Rv2450c belong to the Hamburg
lineage only indicating a further sub-branching in this new
described lineage.
The superior classification of the strains into various phyloge-
netic lineages is also shown in the maximum parsimony tree
calculated based on the SNP data (Figure 3). The tree reveals the
high resolution classification of the analyzed strains into the
phylogenetic lineages of the MTBC, obviously with high specificity
and a high sensitivity as it is shown by the clear identification of the
single M. africanum West African 1 and M. bovis strain in the study
population, respectively. Again SNP based phylogeny reflects the
phylogenetic classification of clinical isolates based on classical
typing methods e.g. MIRU-VNTR typing (data not shown),
however, with a much higher accuracy/confidence for the
classification of known and new groups esp. in the Euro-American
lineage.
Finally, as the analysis of 26 or even 11 genes for larger clinical
isolates is still time consuming and costly, we developed a decision
tree comprising the most variable genes but still allowing the
classification of MTBC strains into the most common phylogenetic
lineages. This diagnostic algorithm comprises sequence analysis of
five genes only (Rv0557, Rv0129c, Rv1009, Rv1811 and Rv2628)
and enables the specific and high resolution classification of
clinical MTBC isolates into 17 different genotypes or phylogenetic
lineages as well as the definition of the M. tuberculosis EAI ‘‘Manila’’
sub-group (Figure 4). This is likely to open the door for cost
efficient and highly specific sequence or SNP based phylogenetic
classification of clinical isolates in larger epidemiological studies.
Discussion
Genetic variability of clinical isolates on the strain level resulting
in various phylogenetic lineages with potential pathobiological
differences as well as the global population structure of MTBC
strains were neglected for decades. Initial studies demonstrated a
high similarity on the DNA level (a sequence similarity of 99.95%).
Genotyping of M. tuberculosis
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highly monomorph bacteria [6,18,23].
However, recent studies showed that clinical isolates are more
genetically distinct than previously assumed and that the genetic
background of strains is responsible for variable pathobiological
characteristics [7,24,25]. Only recently, it was shown that genomic
variation is mainly driven by a high degree of diversity in form of
SNPs, the majority of them being non-synonymous with potential
functional consequences [7,16].
The pathobiological importance of this genotype diversity has
been confirmed by demonstrating enhanced spread of strains of
particular lineages, e.g., in the context of multidrug resistance [26],
defining lineage-specific disease characteristics [27,28], and
confirming host–pathogen co-evolution and specific host–patho-
gen interactions [29–31]. Very recently, we demonstrated
significant levels of phylogenetically based transcriptome diversity
of clinical MTBC isolates upon infection of mouse macrophages
using microarrays [24].
These preliminary findings are challenging and argue strongly
for larger research projects investigating MTBC pathobiological
diversity in the context of TB control or drug and vaccine
development. However, to study the importance of MTBC
pathogenetic diversity and define local and global population
structure, a valid identification of various phylogenetic lineages is a
precondition. Ideally, the applied method shall be cost effective
and applicable in a high throughput format in larger studies.
Recently we showed that SNPs are likely to be the most valid
markers due to the very low level of homoplasy and that they are
ideally suited for defining phylogenetic groupings with very high
confidence [25]. Additionally, recent genome analysis revealed the
presence of high numbers of lineage specific SNPs that allow a
highly robust phylogeny [16]. However, due to the comparably
low level of diversity (1 SNP in 3000 bp) in the genomes of MTBC
strains, it is still challenging to define a SNP panel comprising a
smaller number of genes that allow a cost effective discrimination
of the MTBC in a high or low throughput manner in laboratories
not equipped with high throughput sequencing technologies.
In the present study, we investigated the genetic diversity of
clinical isolates representing different genotypes in 26 genes by de
novo sequencing generating approx. 20.000 bp sequence informa-
tion per strain. The gene set comprised cell wall associated genes,
antigens, genes involved in metabolism, resusciation factors and
other genes of special interest [7]. In addition, as an important step
towards a most valid SNP classification scheme, we carried out the
Figure 3. Maximum Parsimomy Tree based on sequencing analyses data of 11 genes in a population based strain collection from
Hamburg, Germany. WA1, M. africanum West African 1; CAS, M. tuberculosis Central Asien; EAI, M. tuberculosis East African Indian; LAM, M.
tuberculosis Latin American Mediterranean; TUR, M. tuberculosis Turkish.
doi:10.1371/journal.pone.0039855.g003
Figure 4. Sequence based algorithm for the classification of clinical isolates in 17 different genotypes and phylogenetic main
groups. M. africanum 1a/1b, West African 1a and West African 1b; M. africanum 2, West African 2; CAS, M. tuberculosis Central Asien; EAI, M.
tuberculosis East African Indian; LAM, M. tuberculosis Latin American Mediterranean; TUR, M. tuberculosis Turkish; wt: wildtype.
doi:10.1371/journal.pone.0039855.g004
Genotyping of M. tuberculosis
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variable set of 11 genes in a population based strain collection
covering all strains from cases with pulmonary TB from the city of
Hamburg, Germany. Finally, we were able to define a diagnostic
algorithm based on the analysis of just five genes which identify the
majority of MTBC phylogenetic lineages with high confidence at
minimal costs.
In comparison to other SNP based classification schemes, our
assay is clearly superior in terms of the small number of genes/
SNPs to be analyzed as well as in the number of genotypes that
can be distinguished. So far, Filliol et al. described in 2006 a
minimal set of 45 informative SNPs to distinguish MTBC strains
[12]. More recently, few studies described SNP sets in cell wall
biosynthesis-associated genes [32], in genes involved in replication,
repair and recombination (3R) [33], as well as an extended
genome wide set of 35 SNPs [34]. However, all studies are
hampered by limited resolution and none of these provided an in
depth evaluation in an unbiased population based strain collection
reflecting the global diversity. On the contrary, our de novo
sequencing approach revealed a high number of lineage specific
SNPs (several of which have not been described before), that
finally define specific markers for nearly all lineages included in a
fairly low number of genes to be analyzed.
Our data on lineage specific SNPs are in accordance with
previous data generated by de novo sequencing of particular gene
sets [7] and by whole genome re-sequencing of MTBC reference
strains [25,32], thus further affirming the validity of the SNPs
included as markers for particular lineages. This has been further
confirmed by the fact that the SNP based classification in both
study collections investigated was in full concordance with
previous classification based on classical typing techniques. Taken
together, our data confirm that SNPs show a very low level of
homoplasy and are eminently suitable as distinct phylogenetic
markers. Therefore, the described diagnostic algorithm based on
sequencing of five highly variable genes maybe a new, easy and
cost effective method for the valid identification of MTBC strains
in epidemiological studies and complements our diagnostic gold
standard genotyping techniques like spoligotyping and MIRU-
VNTR typing.
The sequence data generated in this study also provided in
depth insights into the population structure and evolution of the
MTBC. The phylogeny derived from the SNP data obtained,
confirm the population structure described by classical molecular
typing methods and by a previous large scale multi locus
sequencing approach analyzing a different set of genes in a
slightly divergent global collection of clinical isolates [4,5]. The
phylogenetic tree confirms the presence of at least 17 MTBC
lineages in the reference collection that are all confirmed by the
presence of specific SNPs. Furthermore, our data sustain the
existence of major clades, clade 1 comprising various M. tuberculosis
genotypes ranging from Beijing, Delhi/CAS to Haarlem and
TUR and clade 2 strains comprising M. africanum West African 1
and 2 and various animal pathogenic species such as M. bovis and
M. caprae. This is in accordance with previous studies based on 24
loci MIRU-VNTR typing and sequence based analysis [4,7].
However, our data reveal the presence of a potential additional
major MTBC clade as M. tuberculosis EAI strains are clearly
separated from all other M. tuberculosis strains, thus likely
representing a third independent main lineage.
Additionally, the present study provides a deeper branching
order of several lineages particularly within clade 2 that can be
investigated by sequential occurrence of shared SNPs. This
analysis nicely confirms the very close relationship of M. bovis
and M. caprae, M. pinnipedii and M. microti, and both M. africanum
lineages. It also indicates that M. tuberculosis EAI strains might be
more closely related to clade 2 rather than to clade 1 strains, which
also raises the question if all MTBC strains are derived from a
single common ancestor.
Another debatable point is whether M. africanum lineages really
constitute a common species as West African 1 and West African 2
strains are separated by several SNPs rendering to a genetic
distance larger than e.g. between M. bovis and M. caprae strains.
Our finding is in concordance with the analysis of the presence or
absence of large chromosomal deletions and with whole genome
analysis of few strains also clearly separating both M. africanum
lineages [25]. Accordingly, species naming and classification needs
to be revised in the light of new genome based data. Furthermore,
the variability of clade 2 lineages might be rather underestimated
as the majority of studies (including ours) are mainly focused on
classical M. tuberculosis strains and include only few strains of M.
africanum or the animal pathogenic species. The same accounts for
the population structure and genetic variability of M. tuberculosis
EAI strains that might constitute a largely uninvestigated new
major branch within the MTBC.
The de novo sequencing of 11 genes in the population based
collection of MTBC strains from Hamburg revealed further
weaknesses of previous studies investigating MTBC population
structure by genomic means that have been mainly based on
reference collections of known genotypes. In addition to the
high concordance of SNP data with previous strain classification
in known lineages, we discovered a potential new subgroup
within the Euro-American lineage. Overall, 18 of 33 Euro-
American strains of the Hamburg collection that were not
classified in a particular lineage by spoligotyping or MIRU-
VNTR data carried a sequence variation in Rv2628 (4t.C) and
could be defined as a new Euro-American sublineage (Hamburg
lineage). Beyond that, 10 of these 18 strains showed a 70 bp
deletion in Rv2450c which identified another subgroup of the
Hamburg lineage. These data indicate that the diversity and the
population structure of the Euro- American lineage might be
largely underestimated and is not well defined yet. Similar
studies applying de novo sequence analysis either based on
selected genes or based on whole genomes are necessary to
better describe the phylogenetic diversity of the MTBC, esp. of
those strains which are not classified yet. Besides, larger studies
on the diversity of clade 2 and the new defined clade 3 strains
are urgently needed.
In accordance with previous studies we also observed that the
overall mutation rates are varying between the different genes in
dependence of the function of the gene product which was
published for other organism previously [23]. For example,
antigens coded by Rv0288 and Rv1980c are comparatively less
variable than cell wall associated genes like Rv0557 which confirm
our recent data obtained from whole genome sequencing of a
smaller collection of MTBC strains [35] indicating that antigens of
M. tuberculosis are evolutionary hyperconserved and nearly
invariable. Contrastingly, functional sequence variations in cell
wall associated genes like in Rv0557 may lead to a higher fitness of
strains or a selection advantage similar to mutations described for
the embB gene coded for a transmembrane arabinosyltransferase
mediating ethambutol resistance [36,37].
Out of all mutations detected in the reference collection 89 let to
an exchange in the amino acid sequence whereas 66 SNPs were
synonymous. That implies a non-synonymous to synonymous ratio
of 1.35 which correlates with the described data for M. bovis and
CDC1551 in comparison to the H37Rv reference strain [18,38].
Our data confirm the hypothesis of a reduced purifying selection
in clinical MTBC isolates [7] caused by the small effective
Genotyping of M. tuberculosis
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transmission.
In conclusion, the diagnostic algorithm developed in our study is
likely to open the door for a high resolution sequence/SNP base
differentiation of the MTBC with a very high specificity. Due to
the small number of genes investigated, low cost sequencing assays
or Real Time PCR assays are desirable. Furthermore, our in depth
de novo sequencing data provide a detailed phylogenetic scenario
for the MTBC that is in major concordance with previous studies.
However, both, the data derived from the global reference
collection as well as from the population based strain collection
indicate that the population diversity in several branches is largely
underestimated and lineage/species naming requires revision
taken new genome data into account. Thus, our data warrant
further in depth analysis of the population structure of the MTBC
esp. of M. africanum and M. tuberculosis EAI strains. In addition,
future studies should step back from reference strain collections
and include more unbiased collections e.g. from population based
epidemiological investigations.
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